Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Sulfuric Acid SCHEMBL27888295 | 1.00 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL27871725 | 1.00 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL7533455 | 1.00 | CA5A (0.50) | — | |
| Sulfuric Acid SCHEMBL1199700 | 1.00 | — | — | |
| Sulfuric Acid SCHEMBL28020955 | 0.96 | — | — | |
| Sulfuric Acid SCHEMBL11400477 | 0.96 | CA5A (0.46) | — | |
| Sulfuric Acid SCHEMBL27918664 | 0.96 | CA5A (0.46) | — | |
| Sulfuric Acid SCHEMBL5462395 | 0.96 | CA5A (0.46) | — | |
| Sulfuric Acid SCHEMBL7886319 | 0.96 | — | — | |
| Sulfuric Acid SCHEMBL2373322 | 0.93 | CA5A (0.43) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117250272-A | Detection method for simultaneously determining two genetic toxin impurities in propranolol hydrochloride | 北京云鹏鹏程医药科技有限公司 | 2023-12-19 | — | — | CN | claimed |
| WO-2007092705-A2 | PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES | CHEMAGIS LTD. (IL) | 2007-08-16 | — | — | WO | claimed |
| US-20070191598-A1 | Process for Preparing Gemcitabine and Associated Intermediates | CHEMAGIS LTD. (IL) | 2007-08-16 | — | — | US | claimed |
| CN-117250272-A | Detection method for simultaneously determining two genetic toxin impurities in propranolol hydrochloride | 北京云鹏鹏程医药科技有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-117250272-A | Detection method for simultaneously determining two genetic toxin impurities in propranolol hydrochloride | 北京云鹏鹏程医药科技有限公司 | 2023-12-19 | — | — | CN | disclosed |
| CN-109839444-B | Process for separating naphthol derivatives and their use | 武汉科福新药有限责任公司 | 2022-03-15 | — | — | CN | disclosed |
| CN-112362780-A | High performance liquid detection method of propranolol hydrochloride | 上海药明康德新药开发有限公司 | 2021-02-12 | — | — | CN | disclosed |
| CN-109839444-A | The separation method of naphthol derivative and its application | 武汉科福新药有限责任公司 | 2019-06-04 | — | — | CN | disclosed |
| US-20090221811-A1 | PROCESS FOR PREPARING GEMCITABINE AND ASSOCIATED INTERMEDIATES | CHEMAGIS LTD. (IL) | 2009-09-03 | — | — | US | disclosed |
| US-20070191598-A1 | Process for Preparing Gemcitabine and Associated Intermediates | CHEMAGIS LTD. (IL) | 2007-08-16 | — | — | US | disclosed |
| US-5409950-A | Anticholesterol, antilipemic agents and an enzyme squalene synthase inhibitors, fungicides | GLAXO GROUP LIMITED (GB) | 1995-04-25 | — | — | US | disclosed |
| EP-0568546-B1 | BRIDGED CYCLIC KETAL DERIVATIVES | GLAXO GROUP LTD (GB) | 1995-04-12 | — | — | EP | disclosed |
| US-5278067-A | Culture product of microorganism Phoma | GLAXO GROUP LIMITED (GB) | 1994-01-11 | — | — | US | disclosed |